11th International Workshop on Waldenstrom's Macroglobulinemia
Attend the world’s most comprehensive hematology/oncology event on Waldenstrom’s macroglobulinemia; the 11th International Workshop on Waldenstrom’s macroglobulinemia (IWWM-11).
The 11th International Workshop for Waldenstrom's Macroglobulinemia is being held October 27th through the 30th, 2022 in Madrid, Spain. The venue chosen for this meeting is one of Madrid’s premier hotels, Westin Palace Madrid, situated in the Las Letras quarter. The hotel nestles in one of the city’s most historic areas linking the city’s most enriching museums, Prado, Reina Sofia and Thyssen-Bornemisza, vibrant parks and gardens, and epicurean eateries. Onsite registration and check-in begin at 14:00 (2:00pm) on Wednesday, October 26th, conference sessions starting on Thursday, the 27th, at 8:00am.
The Workshop’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic system, by promoting targeted research, clinical care methods, education, training, and advocacy for Waldenstrom’s macroglobulinemia.
IWWM-11 will continue to support future research by including a Junior Investigator Poster presentation event with short oral presentations. Abstract submissions for poster presentations will begin in June 2022.
Read more: 11th International Workshop on Waldenstrom's Macroglobulinemia
Waldenstrom's Macroglobulinemia Clinic
The Waldenstrom's Macroglobulinemia Clinic at the DFCI is devoted to the care of patients with Waldenstrom's Macroglobulinemia and related IgM disorders, including IgM MGUS, Myeloma and Neuropathies.
For more information on the WM Clinic at DFCI, please visit the DFCI Center for Hematologic-Oncology/Waldenstrom's Macroglobulinemia Clinic.
Basic Research
Waldenström’s macroglobulinemia (WM) is a distinct B-cell malignancythat results from the accumulation, predominantly in the bone marrow, of clonally related B type lymphocytes, lymphoplasmacytic cells and plasma cells which secrete a monoclonal IgM protein.1 This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the World Health Organization classification system.2 Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG and non-secreting LPL ...
Latest Bing Center News
My Waldenström Macroglobulinemia, Miracle Number Three
Dear Fellow Cancer Patient: As I believe in universal love for ALL, I’m reaching out to you, whether we have met or not, to invite you to join me in embracing the concept of medical miracles no matter what kind of cancer you have.
Update on Bing Neel Syndrome - Shayna Sarosiek April, 2023
From Bing-Neel Co-Leader & Lifeline Volunteer, Julie Davidson: "The Bing-Neel Support Group just had our Spring meeting. We featured a wonderfully informative video by Dr. Shayna Sarosiek, senior physician at the Dana-Farber Cancer Institute’s Bing Center for Waldenstrom’s Macroglobulinemia.
2022 March Dr. Treon "Rounds" with Canadian Medical Professionals
We invited Canadian medical professionals to listen to Dr. Treon of the DFCI. (There were 2 sessions - EST & PST) He provided a very thorough update on the state of WM and its treatment.
IWWM-11 (Madrid 2022) Consensus Panel Reports
Consensus panel reports from the 11th International Workshop on Waldenstrom's Macroglobulinemia.
Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer
Researchers at Dana-Farber have put together a data atlas that includes a range of genomic, transcriptomic, epigenetic, and clinical data from patients and healthy donors to try to understand familial WM.
Topics from the 11th IWWM Workshop in Madrid
Bing Center WM experts discuss various topics from the 11th IWWM in Madrid.
Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients
What should you know if you or a loved one has been diagnosed with Waldenström macroglobulinemia (WM)? Dr. Shayna Sarosiek of the Dana-Farber Cancer Institute shares key advice.
Talking with your Waldenstrom's Macroglobulinemia Patients
This document, written by Drs. Jorge Castillo and Shayna Sarosiek, provides a reference guide to assist medical professionals in discussions with WM patients. Patients can give this booklet to their PCP, oncologist, or other health care provider in order to help familiarize them with this uncommon disease.
2022 ASH Conference Report: Waldenstrom Macroglobulinemia
From the 64th ASH Annual Meeting, Jorge Castillo, MD, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, updates our Waldenström patient community on important research results presented this year, offers guidance on finding relevant clinical trials, and highlights what to look for in the coming year.
RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease
RECORDING NOW AVIALABLE! Join IWMF on ZOOM for this very important topic that affects everyone with a WM diagnosis! Dr. Jorge Castillo presents - Treatments, Trials, and Hope – for ALL Stages of Disease. Dr. Castillo is a GLOBAL SPECIALIST IN Waldenstrom's Macroglobulinemia (WM) AND Clinical Director of the Bing Center Clinic (for WM) at Dana-Farber Cancer Institute.